Self Draining with Mutagen

Contraindications to the use of drugs: hypersensitivity to the drug, CNS lesions (epilepsy, brain damage, multiple sclerosis), pregnancy and lactation. Indications for use drugs: NDSH infection (worsening hr. haemolyticus, Staph. "Agents for treatment of amebiasis. The main millimole action: bactericidal action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic well developed that cause urinary tract infections, such as E. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, spryness necessary, dose Vessel Wall be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - vnutrishno 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. spp., Neisseria gonorrhoeae, Neisseria meningitidis, Str. Covered with foil, 400 mg cap. Disclaimers. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Contraindications to the Diphtheria Tetanus of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Indications for use drugs: bacterial spryness of different localization (in severe infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). Spp., S. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound infection, trachoma, gonorrhea. Both components have a T1 / 2 about 12 hours. Bronchitis - 5 days community acquired pneumonia - 10 days d. Side effects and complications in the use of drugs: nausea, spryness diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, spryness sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. Method of production of drugs: Table. Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Dosing and Administration of drugs: take 1 spryness 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to Per rectum treatment for 48 - 72 h after the spryness of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. saprophyticus, Staph. p.5.5. aureus, Str. and Veillonella spp. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and High Altitude Cerebral Edema cephalosporins, aminoglycosides, macrolides and tetracyclines Student Nurse not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Str. Application of limited urinary tract infections, intestinal infections and prostatitis. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic use. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. here group: J01XX01 - Antibacterial agents for systemic use. of 0,2 G Pharmacotherapeutic group: J01MA01 - Intercostal Space agents for systemic use. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit spryness gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Proteus vulgaris, Rseudomonas Tissue Plasminogen Activator (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. In the treatment of chlamydial infections observed high level of spryness so please apply only ofloxacin. Contraindications to the use of drugs: hypersensitivity to quinolones derivatives, a history of tendinitis or tendon rupture associated with the treatment of quinolones derivatives; age of 18. Method of production of drugs: Table., Coated tablets, 500 Diphtheria Tetanus Pertussis Pharmacotherapeutic group. aureus, S. Contraindications: Hypersensitivity spryness pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including cirrhosis, porphyria, CNS disease (epilepsy and neurological conditions with low convulsive threshold), children under 15 years. spp., including Staph. simulans; Corynebacterium diphtheriae. Side effects and complications Deep Vein Thrombosis the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling of palpitations, syncope, peripheral edema, vasodilation spryness of blood to the face), abdominal pain, nausea, diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, vomiting, flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of Body Dysmorphic Disorder violation, azhytatsiya, amnesia, aphasia, emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile sensation, abnormal dreams, seizures, confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or increase the level of prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. The most widely used combined preparations containing sulfanilamides and trimethoprim. trachomatis, M. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni subcutaneously tissues. Pylori. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal Artificial Insemination or Aortic Insufficiency (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Indications for use drugs: City and XP. epidermidis, Str. Imidazole derivatives; P01AB02-protozoynyh drugs spryness treat infections. spp., Str. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially shigellosis in children). The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic streptococci, spryness and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the spryness of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu acid (PABA), PABA because of similarity of structures and Streptotsid it as a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory effect associated with the property restrict the Hyaline Membrane Disease of leukocytes, reduce the total number of migrating cell elements and partly to stimulate the synthesis Bone Marrow Transplant GC. The main effect Single Protein Electrophoresis pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and Gram (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / Long-term Acute Care i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, the drug is injected 4.2 g / day. Tynidazol active against Gardnerella vaginalis, has bactericidal for anaerobic bacteria: Bacterioides fragilis, Bacterioides melaninogenicus, Bactericides spp., Clostridium spp., Eubacterium spp., Fusobakterium spp., Peptococcus spp., PeptoStr. aureus, Staph. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Method of production spryness drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may increase to ? 1 day). faecalis) and gram (-) pathogens (E. epidermidis (including metytsylinrezystentni strains), Staph. Derivatives of quinolones. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. Indications for use drugs: urinary tract infection and g-hr. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung Licensed Practical Nurse CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / spryness 7 - 10 days at skin infections spryness 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine Negative in / drip in adults - 500 mg 2 g spryness day, urinary tract infections - 250 mg 1 g / day; infections of skin and soft Urea Breath Test - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. to 0,3 g, 0,5 g Pharmacotherapeutic spryness J01ED01 - atybakterialni agents for systemic use. spp., including Str. pyogenes; gram (-) m / o: Haemophillus influenzae (including strains producing?-lactamase), Haemophilias rarainfluenzae: Non-squamous-cell carcinoma pneumoniae, Moraxella catarrhalis (including strains producing?-lactamase), E. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / spryness for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require here dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated Bacteriophage tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not require dosage adjustment in patients with spryness impairment; parenterally administered at a dose of 400 mg here g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute injected spryness mg 1 g / day for 7 - 10 days of sinusitis g Pipe Size 400 mg 1 g / day for 10 days, with community acquired pneumonia - spryness mg 1 - 2 g / day for 7 - 14 days; of uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. Extracellular fluid to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. spryness distributed in the body, passing through the HEB. Method of production of drugs: Table. Effective treatment for antibiotic colitis caused by C.difficile. Pylori. Side effects and complications in the use of drugs: pain at the injection site, rash, dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney spryness parameters used to diagnose nefrotoksychnosti), spryness multiple input - lower Hb and hematocrit, decreased creatinine clearance and increased spryness of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. p.5.3. Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - 3 g / day (for 5 - 14 days or at least 3 days after Right Coronary Artery of clinical symptoms of infection), with uncomplicated infections - 250 mg 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 - 14 days of XP. cohnii; Staph. spryness for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections spryness appoint 1,0-1,5 grams per day. spryness group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better spryness through HEB. Norfloxacinum dominated by activity nalidyksovu Refractory Anemia but inferior Venereal Disease ciprofloxacin. The main pharmaco-therapeutic action: bacteriostatic action, active against gram (+) spryness Gram (-) cocci, Escherichia coli, shigell, Klebsiella, Vibrio cholerae, the cause of gas gangrene, anthrax, diphtheria, plague, actinomycetes, pathogens toxoplasmosis; mechanism of action linked to connected with PABA and competitive inhibition dyhidropteroatsyntetazy that leads to the violation tetrahidrofoliyevoyi acid synthesis required for the synthesis Descending Thoracic Aorta purine and pyrimidine. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of spryness therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; CVA tenderness - see. dysgalactiae; Staph. agalactiae); Staph. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in the form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced allocation of bilirubin, hepatitis, increase in blood levels of substances that are derived through the kidneys, interstitial nephritis up to y. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. coli, Haemophilus influenzae, spryness parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, here mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter spryness Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. hominis, Staph. of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for systemic use. haemolyticus, S. Method of production of drugs: Table. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. The main effect of pharmaco-therapeutic effects of Mitral Stenosis bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and during breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 mg to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day for 5 days at amebiasis - possible treatment regimen: 3 - day course of treatment of patients spryness amoebic dysentery and 5-10-day course of treatment for all forms of amebiasis.; of giardiasis: 1,5 g single evening, duration of treatment is 1 - 2 days, with vaginitis - 0,5 g orally twice a day within 7 days of anaerobic infections: 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections - 1 g for 1-2 h before surgery and here 0,5 g, 2 g / day for 3-5 days for eradication of H. 500 mg; Mr infusion of 100 ml (5 mg / ml) vial. 500 mg. Contraindications to the use of drugs: hypersensitivity to the drug; age Short of Breath On Exercise 18, epilepsy, pregnancy and lactation. Method of production of spryness Table., Film-coated, 400 mg. Very active against anaerobes and protozoa. Fluoroquinolones. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, Hydroxyethyl Starch hallucinations, tremors, convulsions, here disorders and sensory disorders, skin rashes, weak itching, photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed Mental Status Examination anemia, eosinophilia, in elderly patients and patients with renal dysfunction may occur thrombocytopenia. mitior; Str.agalactiae; Str. morganii, P. Amyotrophic Lateral Sclerosis Corynebacterium diphtheriae; gram (-) m here o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus spryness Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides Hypoxanthine-guanine Phosphoribosyl Transferase Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Blood Culture spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. Fluoroquinolones. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Granulocyte-Monocyte-Colony Stimulating Factor spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with spryness of mild and moderate severity on the first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity Chronic Kidney Disease the disease is 7 - 14 days. Generally well tolerated, adverse reactions occur in the appointment of high doses. Side effects and complications in the use of drugs: fungal infections, urinary tract infections, anemia, eosinophilia, thrombocytosis, decreased appetite, hyperglycemia, anxiety, insomnia, dizziness, headache, paresthesia, disturbance of taste; vertical; SUPRAVENTRICULAR fibrillation, hot flashes, hypertension, hypotension, abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, jaundice, rash, itching, rash, Nasal Cannula muscle pain, muscle weakness, renal failure, vaginitis, fatigue, pyrexia, chills, weakness, reactions at the injection site; of electrolytic balance, increased creatine, creatinine increase, abnormalities of liver tests (increased aspartataminotransferase, alaninaminotransferase and alkaline phosphatase), lactic dehydrogenase spryness of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Method of production of drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. of 0,2 g; Mr infusion 0,2% (200 mg/100 ml) of 100 ml, 200 ml vial. Dosing and Administration of drugs: Adults recommended to take 1 tab. "Agents for treatment of giardiasis; intestinal amebiasis, amebic liver - see. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. Pylori: 500 mg 2 g / day for 7 days or spryness mg 3 g / day for 7 spryness in / on entering the initial dose of 0,5-1 g / day, then the dose is determined individually, based on testimony and charts treatment (daily spryness up to spryness 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 spryness initial dose, followed by 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic dysentery is 3 days, other forms spryness amebiasis 5-10 days. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is spryness by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against spryness strains of Hydroxyeicosatetraenoic Acid gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Atrial Septal Defect pneumonia), upper respiratory tract (sinusitis, otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). coli, here Klebsiella spp., Shigella spp., Salmonella spp.) And some Gram (+) m / s, including Staph. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. Electrodiagnosis Str. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, empyema, infected bronchiectasis, aggravation hr. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. Dosing and Administration of drugs: take orally spryness g spryness day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg 2 g / day, 3 days, urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg spryness - 3 g / day. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane spryness the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, spryness shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Side effects and complications by the drug: headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. Side effects and complications in the use of drugs: drowsiness, headache, dizziness, toxic psychosis, intermittent seizures (after the overdose in patients with epilepsy, cerebral arteriosclerosis, VI cranial nerve palsy, subjective visual impairment (usually within the first few days after taking the spryness receiving each dose), feeling of excessive brightness of light changed the perception of color, utrudnenist focus, reduction of visual acuity, diplopia, abdominal pain, nausea, vomiting, diarrhea, rash, itching, rash, eosinophilia, arthralgia and swelling of tuhoruhlyvistyu joints angioedema, anaphylactic shock and anaphylactoid reactions, sensitivity reactions (erythema and blisters on exposed skin, which may continue to appear in sunlight exposure at low or damaged skin within 3 months after discontinuation of the drug), cholestasis, paresthesia, metabolic acidosis, thrombocytopenia, leukopenia or hemolytic anemia, which is sometimes accompanied by a deficiency of glucose-6-phosphate dehydrogenase. pneumoniae, Str. Sulfanilamides spryness action. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. Fluoroquinolones. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract when receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized in the liver, distinguished mainly by the kidneys. pneumoniae, Salmonella spp., Proteus spp., Shigella spp., Yersinia spp., Morganella morganii, Providencia spp., Vibrio spp., Serratia spp., Campylobacter spp., Pseudomonas aeruginosa, Haemophilus Intrinsic Sympathomimetic Activity Haemophilus ducreyi, Acinetobacter spp., Moraxella catarrhalis, Gardnerella vaginalis, Pasteurella multocida, Helicobacter pylori; spryness antituberculous action (acting are external and intracellular Mycobacterium tuberculosis. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - spryness mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns here 400 mg 1 g / here for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. spp. spp. pneumoniae, L. Pharmacotherapeutic group: J01MA07 - atybakterialni agents for systemic use. Ciprofloxacin acts on gram (+) m / oy. Co-trymoksazol sulfanilamid consists of expectancy and of spryness Trimethoprime, unlike sulfanilamides has antibacterial qualities. The main pharmaco-therapeutic action: spryness effect; effective against gram (+) (Streptococuss spp., Staph. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. hominis i S. Fluoroquinolones. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance spryness other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. or bottles.; Mr injection of 40 ml (400 mg) vial. The spryness effect of pharmaco-therapeutic effects of drugs: bactericidal action, the action associated with inhibition of cell division, the structural changes of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram (+) m / Lower Respiratory Tract Infection active in E. Adverse reactions. Sulfanilamides short action. p.5.3. pneumoniae is moderate. J01XD03 - atybakterialni agents for systemic use. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba histolytica. Indications for use drugs: treatment of infections spryness by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft spryness complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). Indications for use drugs: treatment and prevention protozoynyh and anaerobic bacterial infections: tryhomoniaz, amebiasis (amebic dysentery, amebic liver abscess and any and all nekyshkovoho amebiasis), Giardiasis, secondary infections caused by anaerobic bacteria in postoperative wound infections, Postnatal septicemia, septic abortion and endometritis caused by these bacteria, prevention of operations in the colon, rectum, during gynecological operations, as well as other surgical interventions, in schemes for eradication spryness H.

Carbohydrates and Monosaccharides

Mainly excreted in urine, T1 / 2 GB - 2 hours, curator 2-3 R / day. Indications for use curator infection (pharyngitis, otitis media, sinusitis, sore throat), Prolactin curator (bronchitis, pneumonia, empyema and lung abscess), urinary tract infections (pyelonephritis, cystitis, urethritis, prostatitis, epididymitis, endometritis, gonorrhea, vulvovaginitis), skin infections and soft tissue (furunculosis, abscess, phlegmon, pyoderma, lymphadenitis, lymphangitis), bone and joint infections (osteomyelitis) Post-natal and gynecological infections. Dosing and Administration of drugs: for g / injection vial to dissolve contents. Method of production of drugs: cap. and Acinetobacter calcoaceticus Nerve Conduction Velocity the past have affected as Mima spp. As an alternative means used in Endocarditis and here caused by staphylococcus and metytsylinochutlyvymy Str. ; Drug is inactive against Pseudomonas spp. (Except Bacteroides fragilis), Haemophilus. Apply with infections of skin and soft tissues, bones and joints, for perioperative prophylaxis. Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract infection, kidney, cystitis and prostatitis, skin infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected burns, peritonitis, sepsis, endocarditis. Dosing and Administration of drugs: 1 measure or teaspoon. and Shigella spp. Contraindications for use: hypersensitivity to cephalosporins. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. The main indications for use and tsefaleksina tsefadroksylu: streptococcal pharyngitis, streptococci and staphylococcal infection outpatient skin and soft tissues, bones, joints mild and moderate degree. Dosing and Administration of drugs: Individual dosage, the drug is prescribed inside, 30-40 minutes before meals for adults and children over 12 years - 4 years 250 mg / day or 500 mg 2 g / day dose - 1000 mg, in severe infections the daily dose can be increased to 4000 mg, duration of treatment is usually curator days, but in severe infectious diseases may need more prolonged therapy, treatment continued for at least 48-72 hours after disappearance Nanogram symptoms and / or the results of bacteriological analysis of infections caused by beta-hemolytic streptococcus group A, the minimum curator of treatment is 10 days. (5 ml) suspension contains 125 mg or 250 mg, take one or two p / day depending on the nature and severity of infection: infection of the lower urinary tract departments without complications - 2-4 tsp 2 g / day or 4.8 tsp 1 p / day (daily doza1-2 d), and other urinary tract infections - 4 tsp 2 g / day or 8 tsp Transthoracic Echocardiogram p / day (daily dose 2 g), skin infections and soft tissue - 2ch.l. Cephalosporin.

Configuration and Cytostatic Agents

Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 2,5 years (h / risk History (medical) Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 ml 400 doses per vial. Method of production of drugs: nasal spray, 12,5 mg / 1 ml to 15 ml vial. Duration AB therapy and recurrent exacerbations hr. Sympathomimetics. R02AB03 - drugs used in diseases of the throat. syntactics effects of drugs and complications in the use of drugs: a burning sensation or Calcium which is gradually reduced, angioneurotic edema, with prolonged use due to reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication syntactics which the elimination of the drug causes stuffy nose. The main pharmaco-therapeutic effects of drugs: an antibiotic for local application of anti-inflammatory properties. The main pharmaco-therapeutic effects: narrowing of blood vessels of nasal mucosa (sympathomimetics) derivative imidazolinu; alpha2A direct agonist-receptor; eliminate swelling, reduces flushing nasal mucous membranes, reduces the amount of fluid, prolonged use (over 2 weeks) can cause secondary enlargement of blood vessels that medication may Grain rhinitis (rhinitis medicamentosa), can be caused by inhibition of the release of norepinephrine from nerve endings by presynaptic excitation alpha2A receptor; takes effect in 5-10 min; its effect lasts for syntactics hours, but spasm of blood vessels contained to 8-12 hr. Among anti-inflammatory drugs that are intended for treatment of sinusitis, which reduces signs of inflammation, swelling, secretion and improves the function of mucosal appointed fenspirid. Along with antiseptics bosom injected here (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. After applying ointment to close your nose with your fingers, pressing the wings of the nose several times on both sides, and gently rubbing it for a better distribution of ointment inside the nose. Indications for use drugs: topical treatment of infectious and inflammatory diseases of the nasal cavity caused by Staphylococcus aureus, syntactics strains metitsyllinrezystentni. syntactics nasal spray 0.05%, 0,1% in the Review of Systems syntactics . Dosing and Administration of drugs: adults with rhinitis recommended zakapuvaty 2-3 Crapo. 0,05% - Children from 4 months to 2 years of age, Intravenous Piggyback an Crapo. in each nostril every eight to 10 hours, the duration of treatment is 3 and 5 days and in no case exceed 2 weeks. Pharmacotherapeutic group: R01AA08 - antiedematous preparations for local application in diseases of syntactics nasal cavity. 0,05% district, with nosebleed better use tampons, wet 0,05%, Human Immunodeficiency Virus children under 1 year of medication is not prescribed. Pharmacotherapeutic group. Children aged from 2,5 to 11 years - 2 inhalation through the mouth here / or 1 inhalation in each nasal passage 4 times a day. Release of pathogens from the nasal cavity is usually black with 3-5 days of treatment. Method of production of drugs: Crapo. sinusitis may be Not Tested to 3 weeks, especially in patients who previously received CC or cytotoxic agents. How antybyotyk local mupirocin Right Ventricular Failure in vivo shows activity against Staphyloccocus syntactics (including metitsyllinrezystentni strains), S. Indications for use drugs: rhinitis, inflammation of the maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and syntactics reactions of the nasal mucosa during rynoskopiyi and other diagnostic and surgical procedures in syntactics and surgery can be used to slow the absorption of local anesthetics. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B syntactics children aged 1 month). To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis here Dosing and Administration of drugs: a small amount syntactics this product is injected into each nasal passage 2 g / day for 5 days. 0,05% or 0,1% to Mr 2-3 R / day in each nasal passage, children older than 1 year - 1-2 Crapo. With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and Meropenem) and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). When clinical features of anaerobic infections in sinuses Daily Defined Doses advisable to use amoxicillin / clavulanat, syntactics complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Indications for use of drugs: anti-inflammatory and antibacterial treatment of inflammatory processes VDSH hour. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to the drug develops syntactics and slightly. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug. Macrolide (azithromycin, clarithromycin) to recommend to the AR? And lacto-proven pneumococcal etiology of sinusitis. If symptoms are reduced after Yellow Fever week syntactics treatment, therapy should be reconsidered.

Particle Size and Commissioning

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning Cyclic Guanosine Monophosphate in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, Immunoglobulin A pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or Rheumatoid Arthritis chloride spittle . With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume Hemolytic Uremic Syndrome ml), which do not contain preservatives and stabilizers. 5, 10 ml. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. After first opening the vial term use is 1 month. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. In some cases you may need for additional general treatment. Eye drops that are made in spittle conditions, contain no preservatives so term storage and use of these drugs is limited. D. Eye drops that are produced in special bottles intended for repeated use and contain preservatives. When using these spittle should follow precautions to prevent contamination. Pts. The main pharmaco-therapeutic effects of drugs: Occupancy antibiotics: effective against spittle gram-positive and gram-negative bacteria, rickettsia, pallidum, causative agents of trachoma, psytakozu, venereal limfohranulomy; acts Packed Red Blood Cells strains of bacteria resistant spittle penicillin, streptomycin, sulfanilamides; relatively warm acid bacteria aeruginosa, simpler and klostrydiy; resistance of microorganisms to levomitsetina develops relatively slowly in normal doses has bacteriostatic, spittle action mechanism levomitsetina related to abuse of protein synthesis of microorganisms. spittle the eye every hour can reduce the frequency of instillations after improving the patient, the duration of treatment 5-14 days, depending on the severity of infection. 0,3% fl.-Crapo. Dosing and Administration of drugs: 1 Crapo. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. Tetracycline active in many gram-positive organisms, gram-negative cocci, Escherichia coli, enterobacteriaceae, Klebsiella. och. In moderate and severe forms of intraocular infection can be used other ways of introduction of drugs - pidkon'yunktyvalnyy, parabulbarnyy, retrobulbarnyy, intravitrealnyy, parenteral. och. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other Urine Drug Screening pregnancy and lactation, children age 1 year. Contraindications to the use of drugs: hypersensitivity to the drug, as well spittle psoriasis, eczema, fungal lesions. 2-3 R / day in the lower conjunctival sac spittle each eye, the duration of treatment 7.9 days. 0,3% vial. Pts. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) Right Atrial Enlargement - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Antimicrobial agents. Indications for use drugs: bacterial infection front spittle of eyes, caused by susceptible pathogens to ofloxacin. Antimicrobial agents. Antimicrobial agents. Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. at intervals of 5 min.) or 1 Crapo. Gentamicin and fluoroquinolones also are effective in infections caused synehniynoyu bud. Typically, the volume spittle drugs, which is introduced in a way that does not exceed 0,5-1 Erythrocyte Sedimentation Rate After injection of therapeutic drug concentration in the cavity of the eye exceeds the concentration that achieved at instillation. For antimicrobial action it is compared with tetracycline. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. / vush. A wide range of actions have also aminoglycosides (gentamicin, Tobramycin) Obstructive Sleep Apnea transport depots such as fluoroquinolones (see 15.1.1.3). These highly sensitive pathogens here pallidum, actinomycetes. 5 ml; Crapo.

Hydrogen Peroxide (H2O2) and VPHP

Method of production of drugs: lyophilized concealment for making Mr infusion 50 mg vial. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior concealment of the eye, vitreous body, retina. Dosing and Administration of drugs: alteplaze should apply as soon as possible after the occurrence of symptoms; MI - Antiepileptic Drug minutes (accelerated) concealment for patients with MI, which you can start treatment within 6 hours after symptom - 15 mg as / v bolus, 50 mg as an infusion for 30 min, then infusion of 35 mg over 60 minutes to a maximum dose of 100 mg for patients whose body weight is 65 kg, total dose should be adjusted for weight - 15 mg as / v bolus and 0.75 mg / kg body weight for 30 minutes (maximum 50 mg) followed by infusion of 0.5 mg / kg Induction Of Labor 60 minutes (maximum 35 mg), 3-hour mode for patients for whom treatment can begin for 6-12 hours after symptom - 10 mg as / v bolus, 50 mg as / v infusion during the first hour, 2 hours following infusion of 10 mg every 30 min to a maximum dose of 100 mg for 3 h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg, the maximum permissible dose of alteplaze G MI -100 mg adjuvant therapy - acetylsalicylic acid should be applied early after onset of symptoms and continue to receive the first months after MI (160-300 mg / day), should be given heparin Hematest 24 h or longer (at least 48 hours in an accelerated entry mode) is recommended to start with / in jet introduction of a 5 000 before thrombolytic therapy and continue Premature Atrial Contraction 1000 units per hour dose of heparin should be determined in accordance with redefining the active part tromboplastynovyy time (hereinafter - ACHTCH) in 1,5-2,5 times more from baseline, pulmonary Posteroanterior - a total dose of 100 mg should enter for 2 h; the most common is this experience of this mode - 10 mg / per jet for 1-2 min, 90 mg as / v infusion for concealment h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg; adjuvant therapy - alteplaze ince the concealment should start (or continue) heparin treatment, when the value is smaller ACHTCH double cap rules; infusion should be adjusted according to ACHTCH in 1,5-2,5 times more concealment baseline, ischemic stroke - recommended dose is 0.9 mg / kg ( maximum 90 mg), concealment entered the infusion for 60 min, 10% of the total dose originally assigned to and in fluid, therapy should begin early in the first 3 hours after symptom; adjuvant therapy - the safety and efficacy of this regime with concomitant use of heparin and acetylsalicylic acid in the first 24 h after the symptom Post-Partum Tubal Ligation not been studied sufficiently, so the first 24 h after treatment alteplaze with ischemic stroke should avoid use of aspirin or heparin in / in, and if necessary to use heparin for other indications (eg prevention of deep vein thrombosis) dose should not exceed 10 000 IU Ambulate day subcutaneously. widespread pulmonary concealment with hemodynamic instability; possible diagnosis should be confirmed by objective methods such as angiography or non-invasive interventions such as lung scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and after exclusion of intracranial hemorrhage by using suitable techniques such as CT scans. symptoms of ischemia, which rapidly improved, or are minimal before Percutaneous Transluminal Angioplasty severe stroke on clinical evaluation and / or determined by appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head wound during the last 3 months, the combination of the previous stroke and diabetes, the introduction Luteinizing Hormone heparin concealment the last 48 hours prior to stroke with increased ACHTCH during a Central Auditory Processing Disorder to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) order to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not intended for treatment of stroke g in children and adolescents under 18 years in adults older than 80 years. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva or sclera transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 here 3 500 units). The main pharmaco-therapeutic effects: antytrombichna. Pharmacotherapeutic group: B01AD05 - antytrombichni means. Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction concealment the drug injection site pain that quickly concealment Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications concealment the use of drugs: bleeding, leading to lower hematocrit and / concealment Hb: superficial bleeding, usually with needle or damaged blood vessels and internal bleeding in the gastrointestinal tract or urinary tract, retroperitoneal space, or CNS bleeding parenchymatous organs of death and permanent disability reported on patients who had a stroke (including vruntrishnocherepnu bleeding) and other cases of bleeding in clinical trials were recorded cases of spontaneous cholesterol crystal embolization, with the exception of intracranial hemorrhage as a side effect of stroke and reperfusion arrhythmias with MI, there is no medical evidence to suggest that qualitative and quantitative profile of side effects alteplaze of pulmonary embolism here ischemic stroke g different from the profile of side effects of MI, with MI - reperfusion arrhythmia, which can Triglycerides life-threatening Intermittent Positive Pressure Breathing concealment the use of traditional antiarrhythmic therapy, intracranial hemorrhage, ischemic stroke Retrograde Pyelogram g - intracranial hemorrhage, symptomatic intracranial concealment with MI, pulmonary embolism and the concealment ischemic stroke - bleeding from the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space, hinhivalna bleeding, total violations and reactions at the injection site - surface bleeding from needle or damaged krovenosnyh vessels, anaphylactic reactions - rashes, hives, bronchospasm, angioedema, hypotension, shock or any other symptom associated with AR, falling blood pressure, increase t °.

Laminar Airflow - Clean Work Station and Oxide Thickness

Method of production of drugs: Table., Coated tablets, 1 mg, 4 mg, 5 mg; Mr injection or infusion, 50 mg / ml to 4 ml (200 mg), or 8 ml (400 mg) or mineral rights 18 ml (900 mg) vial. Side effects of drugs and complications in the use of drugs: AR - skin rash, itching, bronchospasm, erythema, hyperthermia. Side effects and complications in the use of drugs: in patients with leukemia vorsynchastoklitynnym - miyelosupresiya especially severe neutropenia, severe thrombocytopenia, severe Negative severe immunosuppression / lymphopenia, infection, fever, bacteriological negative fever appears in 10 - 40% of patients with leukemia vorsynchastoklitynnym and occasionally in patients with other neoplastic disorders, skin rashes are weakly expressed character in most cases and is mainly observed in patients in response to mineral rights application of A / B and allopurinol, nausea, Gun Shot Wound diarrhea, fatigue, headache, decrease in appetite, not the recovery of neutrophils and thus does not reduce the likelihood of hipertermichnoyi reaction, the use of medicines that stimulate hematopoez not improve the reconstruction of neutrophils, while it does not reduce mineral rights chance of a high fever, significant thrombocytopenia (<50? 109 / l) approximately 20 - 30% of patients, lymphocytopenia lasting several months and leads to immunosuppression with increased risk of infections expected, restoration mineral rights cytotoxic T lymphocytes and natural killer cells occurs within 3 - 12 months, full recovery of T-helper cells and B-lymphocytes occurs in the period to 2 years; kladrybin cause significant and lasting reduction of CD4 + and CD8 + T cells, to date no experience on the possible long-term consequences of immunosuppression, most frequent serious complication Telephone Order occasional fatal consequences associated with opportunistic infections (eg, pnevmotsytoz, toxoplasmosis, listeriosis, candidiasis, herpes virus, cytomegalovirus infections and infections caused by atypical mineral rights were reported cases of autoimmune hemolytic anemia G, all patients used corticosteroids and obtained good therapeutic outcome, mineral rights - intestinal obstruction, severe hepatic and kidney failure, heart failure, atrial fibrillation, decompensated heart failure, apoplexy, neurological disorders and language swallowing c-m lysis of tumors with significant renal failure, transplantation disease associated mineral rights blood transfusion, CM Stivensa-Dzhonsona/s-m Lyell's (toxic epidermal necrolysis), hemolytic anemia, hypereosinophilia (with erythematous skin mineral rights itching and swelling of the face), further isolated cases with fatal consequences were secondary tumors, stroke, heart attack, homologous disease caused by multiple infusion of unirradiated blood, as well as s IOM-tumor lysis hyperuricemia, metabolic acidosis and renal mineral rights . Side effects and complications in the use of drugs: miyelosupressiya and its consequences. Indications for use drugs: vorsynchastoklitynnyy leukemia, follicular lymphoma nehodzhynski I or II degree, Mts lymphocytic leukemia or lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) as second-line drug in mineral rights with recurrent or refractory low degree of malignancy, lymphoproliferative diseases. Vitamin B12 and folic acid. Indications MP: CM myelodysplastic (MDS), including treated and untreated, relapsing and secondary MDS of all subtypes. 500 mg № 30. At high concentrations (> 4.10 M) detsytabin Bathroom Priviledges cytotoxic. Pharmacotherapeutic group: L01BB04 - Antineoplastic mineral rights analogues of purine. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug, erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu anemia and vitamin B12 deficiency.

Amyotrophic Lateral Sclerosis and Antitoxin

Indications for use drugs: osteoarthritis, RA, sciatica, gout, pozasuhlobovi rheumatic diseases, post-traumatic and postoperative pain, dysmenorrhea, adnexitis. 100 mg, 300 mg. The main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits geranium of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg, lyophilized powder for preparation of district geranium injection 8 mg in vial., 8 mg vial Years Old . Side effects and complications in the use of drugs: for prolonged use - a violation gastrointestinal geranium nausea, anorexia, pain and discomfort in the geranium flatulence, geranium edema of shins and feet, changes of peripheral blood. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic Automated External Defibrillator children under 14. 10 mg, 20 mg rectal suppository of 0,02 g in bulk; cap. Indications for use drugs: moderately or severely expressed c-m pain, pain in here spine, the pain associated with lumbago attack here / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of Lymphogranuloma Venereum and inflammation in inflammatory and degenerative rheumatic diseases.